For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250731:nRSe2538Ta&default-theme=true
RNS Number : 2538T CAP-XX Limited 31 July 2025
31 July 2025
CAP‑XX Limited
("CAP‑XX" or the "Company")
Total voting rights
CAP‑XX Limited (LSE: CPX), a global leader in supercapacitor technology,
confirms that the Company's issued ordinary share capital as at the date of
this announcement comprises 5,790,023,753 ordinary shares with one voting
right each. The Company does not hold any ordinary shares in treasury.
Therefore, the total number of ordinary shares and voting rights in the
Company is 5,790,023,753.
The above figure may be used by shareholders in the Company as the denominator
for the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the share capital
of the Company.
For further information, please contact:
CAP-XX Limited
Dr Graham Cooley
(Chairman)
+61 (2) 9157 0000
Lars Stegmann (Chief Executive Officer)
Allenby Capital (Nominated Adviser and Broker)
David Hart/Piers Shimwell (Corporate Finance)
+44 (0) 20 3328 5656
Jos Pinnington/Tony Quirke (Sales and Corporate Broking)
Notes to Editors:
CAP-XX (LSE: CPX) is a leader in the design and manufacture of thin, flat
supercapacitors and energy management systems used in portable and small-scale
electronic devices, and to an increasing extent, in larger applications such
as automotive and renewable energy. The unique feature of CAP-XX
supercapacitors is their very high-power density and high energy storage
capacity in a space-efficient prismatic package. These attributes are
essential in power-hungry consumer and industrial electronics and deliver
similar benefits in automotive and other transportation applications.
For more information about CAP-XX, visit www.cap-xx.com
(http://www.cap-xx.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVRSDLFISEISEFW